AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,326,781 | -35.0% | 299,457 | -19.0% | 0.00% | 0.0% |
Q2 2023 | $3,579,267 | -10.9% | 369,759 | +0.9% | 0.00% | -50.0% |
Q1 2023 | $4,016,029 | +596.1% | 366,426 | +174.4% | 0.00% | – |
Q4 2022 | $576,971 | -81.1% | 133,558 | -67.1% | 0.00% | -100.0% |
Q3 2022 | $3,053,000 | -48.4% | 405,991 | -31.1% | 0.00% | -66.7% |
Q2 2022 | $5,921,000 | -75.0% | 589,096 | -69.2% | 0.00% | -62.5% |
Q1 2022 | $23,653,000 | -61.6% | 1,910,681 | -29.1% | 0.01% | -61.9% |
Q4 2021 | $61,672,000 | +8.2% | 2,696,667 | +1.1% | 0.02% | 0.0% |
Q3 2021 | $56,997,000 | +346.2% | 2,666,536 | +170.5% | 0.02% | +320.0% |
Q2 2021 | $12,775,000 | +391.3% | 985,770 | +392.4% | 0.01% | +400.0% |
Q1 2021 | $2,600,000 | -70.5% | 200,211 | -68.5% | 0.00% | -75.0% |
Q4 2020 | $8,799,000 | +150.3% | 636,183 | +166.5% | 0.00% | +300.0% |
Q3 2020 | $3,516,000 | +2.6% | 238,693 | +13.2% | 0.00% | -66.7% |
Q2 2020 | $3,426,000 | +347.3% | 210,776 | +299.2% | 0.00% | +200.0% |
Q1 2020 | $766,000 | -58.1% | 52,800 | -41.5% | 0.00% | -66.7% |
Q4 2019 | $1,827,000 | +903.8% | 90,224 | +229.8% | 0.00% | – |
Q3 2018 | $182,000 | +188.9% | 27,358 | +172.5% | 0.00% | – |
Q3 2017 | $63,000 | -59.4% | 10,041 | -52.4% | 0.00% | -100.0% |
Q1 2017 | $155,000 | – | 21,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |